Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-04-26

Clinical Trial Update: Norepinephrine Exerts an Inotropic Effect at the Early Phase of Human Septic Shock

View source ↗

Summary

A completed clinical trial evaluated norepinephrine for its inotropic effects in the early phase of septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Hopital Antoine Beclere | Conditions: Septic Shock | Status: COMPLETED